Cargando…

αTAT1: a potential therapeutic target in cancer?

Detalles Bibliográficos
Autores principales:	Chien, J-Y, Lin, C-H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	News and Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823947/ https://www.ncbi.nlm.nih.gov/pubmed/27031969 http://dx.doi.org/10.1038/cddis.2016.46

Ejemplares similares

First MCL-1-selective BH3 mimetics as potential therapeutics for targeted treatment of cancer
por: Besbes, S, et al.
Publicado: (2015)

A reversal of Tat
por: Tuma, Rabiya S.
Publicado: (2005)

Tat substrates open the portal
por: Short, Ben
Publicado: (2014)

Sec and Tat share the workload
por: Short, Ben
Publicado: (2012)

αTAT1 downregulation induces mitotic catastrophe in HeLa and A549 cells
por: Chien, J-Y, et al.
Publicado: (2016)

HIV-1 Tat, apoptosis and the mitochondria: a tubulin link?
por: Giacca, Mauro
Publicado: (2005)

Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016)

Histamine: a potential cytoprotective agent to improve cancer therapy?
por: Martinel Lamas, D J, et al.
Publicado: (2015)

HIV-1 Tat: Its Dependence on Host Factors is Crystal Clear
por: D’Orso, Iván, et al.
Publicado: (2010)

Discovery of a novel target for cancer: PRR14
por: Xiao, Shaowen, et al.
Publicado: (2016)

Unexpected Mutations in HIV-1 That Confer Resistance to the Tat Inhibitor Didehydro-Cortistatin A
por: Rice, Andrew P.
Publicado: (2019)

An Ounce of Tat Prevention Is Worth a Pound of Functional Cure
por: Planelles, Vicente
Publicado: (2015)

Neuroprotective and neurorestorative potential of xenon
por: Lavaur, J, et al.
Publicado: (2016)

Transgelin in bladder cancer: A potential biomarker and therapeutic target
por: Li, Wei-Ming, et al.
Publicado: (2019)

A transcription factor 7-like 1-lipocalin 2 axis in the differentiation of keratinocytes
por: Liu, Y, et al.
Publicado: (2016)

Developments in the Role of Endothelin-1 in Atherosclerosis: A Potential Therapeutic Target?
por: Sutton, Greg, et al.
Publicado: (2019)

Depicting Binding-Mediated Translocation of HIV-1 Tat Peptides in Living Cells with Nanoscale Pens of Tat-Conjugated Quantum Dots
por: Lin, Chien Y., et al.
Publicado: (2017)

A target of potential RELAvance in inflammatory breast cancer
por: Eckhardt, Bedrich L., et al.
Publicado: (2017)

Beta-2 Agonism: A Potential Therapeutic Target for Dyslipidemia
por: Davidson, Michael H.
Publicado: (2015)

Orai1 as a potential “fits-all approach” therapeutic target for the treatment of DMD
por: Cheng, Arthur J., et al.
Publicado: (2023)

Coagulation factor VII and malignant progression of hepatocellular carcinoma
por: Chen, K-D, et al.
Publicado: (2016)

Vitamin D as a Potential Therapeutic Target and Prognostic Marker for Colorectal Cancer
por: Bintintan, Vasile V.
Publicado: (2018)

Bcl-2 together with PI3K p110α regulates cell morphology and cell migration
por: Wan, G, et al.
Publicado: (2015)

Paracrine regulation in mesenchymal stem cells: the role of Rap1
por: Zhang, Y, et al.
Publicado: (2015)

The potential of erythrocytes as cellular aging models
por: Kaestner, Lars, et al.
Publicado: (2017)

Diet-driven interferon-γ enhances malignant transformation of primary bovine mammary epithelial cells through nutrient sensor GCN2-activated autophagy
por: Xia, X-j, et al.
Publicado: (2016)

TSPO as a target for treatments of diseases, including neuropathological disorders
por: Veenman, L, et al.
Publicado: (2015)

Thrombospondin1 as a potential therapeutic target for human nonalcoholic fatty liver disease
por: Song, Yongfeng, et al.
Publicado: (2020)

Selective inhibitors of nuclear export: potential therapeutics for AR variant-expressing prostate cancer
por: Antonarakis, Emmanuel S.
Publicado: (2018)

p53-guided response to nucleostemin loss in normal versus cancer cells
por: Tsai, R Y L
Publicado: (2015)

Cancer cell resistance to anoikis: MUC1 glycosylation comes to play
por: Yu, Lu-Gang
Publicado: (2017)

A minimal ING1b fragment that improves the efficacy of HDAC-based cancer cell killing
por: Boyko, A, et al.
Publicado: (2015)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
por: Zheng, Xuewei, et al.
Publicado: (2022)

Silencing of RUNX2 enhances gemcitabine sensitivity of p53-deficient human pancreatic cancer AsPC-1 cells through the stimulation of TAp63-mediated cell death
por: Sugimoto, H, et al.
Publicado: (2015)

Deciphering the true antiproliferative target of an MK2 activation inhibitor in glioblastoma
por: Brennan, P E
Publicado: (2016)

A cascade of protein aggregation bombards mitochondria for neurodegeneration and apoptosis under WWOX deficiency
por: Sze, C I, et al.
Publicado: (2015)

The lure of the lipids: how defensins exploit membrane phospholipids to induce cytolysis in target cells
por: Baxter, Amy A, et al.
Publicado: (2017)

Mitochondrial DNA as an initiator of tumorigenesis
por: Lee, W T Y, et al.
Publicado: (2016)

Necrotic cone photoreceptor cell death in retinitis pigmentosa
por: Murakami, Y, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vntigo2i4se30lotqe8glhiego